Combination of pravastatin and cyclosporin in transplant patients.
Christians
U
U
D000924:Anticholesteremic Agents / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000627:therapeutic use; D016572:Cyclosporine / Q000494:pharmacology* / Q000627:therapeutic use; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D016027:Heart Transplantation; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007166:Immunosuppressive Agents / Q000494:pharmacology* / Q000627:therapeutic use; D016030:Kidney Transplantation; D017035:Pravastatin / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000627:therapeutic use
D000924:Anticholesteremic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D017035:Pravastatin